Zivo Bioscience, Inc. (ZIVO) shareholders
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Laith Yaldoo Joint filing with HEP Investments LLC (15.34%) | 530,989 | 15.34% | 13D (active) amendment | Jun 28, 2024 |
| Hep Investments LLC Joint filing with Yaldoo Laith L (17.80%) | 488,785 | 17.80% | 13D (active) amendment | Dec 5, 2023 |
| Mark E. Strome Joint filing with Strome Group, Inc. (7.13%), Strome Investment Management, LP (7.13%) and 1 more | 472,942 | 12.10% | 13D (active) amendment | Dec 31, 2025 |
| Christopher D. Maggiore | 458,371 | – | 13D (active) amendment | Jun 5, 2024 |
| Keith Marchiando | 341,616 | 9.40% | 13D (active) | Jun 5, 2024 |
| John Bernard Payne | 305,871 | 8.50% | 13D (active) | Jun 5, 2024 |
| Alison A. Cornell | 242,212 | 7.40% | 13D (active) | Jun 5, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ZIVO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | 4,360 | 0.11% | $17.57K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.1% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q1 2026 | 2 | 0M | 0.1% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2025 | 3 | 0M | 0.1% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 2 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 2 | 0M | 0.1% | 2 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2023 | 2 | 0M | 0.0% | 2 / 0 | 0 / 1 | 0M | 0M |
| Q3 2023 | 2 | 0M | 0.1% | 0 / 0 | 1 / 0 | 0M | 0M |
| Q2 2023 | 2 | 0M | 0.1% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q1 2023 | 1 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Bernard Payne | President and CEO, Director | 19,618 | 0.50% | Jan 28, 2026 |
| William A. Sullivan | Chief Financial Officer | 0 | – | Dec 29, 2025 |
| Laith L. Yaldoo | Director, 10% owner | 1,125,726 | 28.95% | Mar 3, 2026 |
| Alison A. Cornell | Director | 279,481 | 7.19% | Jan 28, 2026 |
| Christopher D. Maggiore | Director, 10% owner | 519,292 | 13.35% | Jan 27, 2026 |
| Nola E. Masterson | Director | 123,378 | 3.17% | Jan 3, 2025 |
| Strome Group, Inc. | – | 472,942 | 12.16% | Apr 24, 2026 |
| Investment Management Lp Strome | – | 572,942 | 14.73% | Apr 24, 2026 |
| Mark E. Strome | 10% owner | 398,683 | 10.25% | Apr 24, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Investment Management Lp Strome – | Apr 17, 2026 | Buy | +100,000 | $2.00 | $200.00K | 572,942 |
| Laith L. Yaldoo Director, 10% owner | Feb 27, 2026 | Buy | +1,543 | $9.72 | $15.00K | 583,615 |
| Strome Group, Inc. – | Feb 12, 2026 | Buy | +20,000 | $9.77 | $195.40K | 472,942 |
| Laith L. Yaldoo Director, 10% owner | Feb 10, 2026 | Buy | +2,434 | $10.27 | $25.00K | 582,072 |
| John Bernard Payne President and CEO, Director | Jan 26, 2026 | Buy | +11,709 | $8.54 | $99.99K | 19,618 |
| Alison A. Cornell Director | Jan 26, 2026 | Buy | +11,709 | $8.54 | $99.99K | 279,481 |
| Laith L. Yaldoo Director, 10% owner | Jan 14, 2026 | Buy | +1,766 | $8.49 | $14.99K | 579,638 |
| Christopher D. Maggiore Director, 10% owner | Jan 14, 2026 | Buy | +1,766 | $8.49 | $14.99K | 519,292 |
| Laith L. Yaldoo Director, 10% owner | Nov 28, 2025 | Buy | +2,777 | $9.00 | $24.99K | 577,872 |
| Investment Management Lp Strome – | Oct 13, 2025 | Buy | +20,259 | $12.34 | $250.00K | 452,942 |
| Laith L. Yaldoo Director, 10% owner | Oct 10, 2025 | Buy | +1,659 | $12.05 | $19.99K | 575,095 |
| Christopher D. Maggiore Director, 10% owner | Oct 8, 2025 | Buy | +23,682 | $12.01 | $284.42K | 517,526 |
| Laith L. Yaldoo Director, 10% owner | Sep 30, 2025 | Buy | +15,322 | $15.99 | $245.00K | 573,436 |
| Laith L. Yaldoo Director, 10% owner | Jun 13, 2025 | Buy | +3,488 | $14.33 | $49.98K | 558,114 |
| Christopher D. Maggiore Director, 10% owner | Apr 8, 2025 | Sale | −20 | $16.25 | $325 | 507,000 |
| Laith L. Yaldoo Director, 10% owner | Jan 22, 2025 | Buy | +7,200 | $17.53 | $126.22K | 551,746 |
| Laith L. Yaldoo Director, 10% owner | Jan 22, 2025 | Buy | +2,880 | $17.53 | $50.49K | 554,626 |
| Investment Management Lp Strome – | Jan 17, 2025 | Other | +34,000 | $18.50 | $629.00K | 432,683 |
| Christopher D. Maggiore Director, 10% owner | Jan 1, 2025 | Award | +7,277 | – | – | 507,020 |
| Christopher D. Maggiore Director, 10% owner | Jan 1, 2025 | Award | +1,300 | – | – | 499,743 |
| Nola E. Masterson Director | Jan 1, 2025 | Award | +1,354 | – | – | 123,378 |
| Nola E. Masterson Director | Jan 1, 2025 | Award | +7,528 | – | – | 130,906 |
| Laith L. Yaldoo Director, 10% owner | Jan 1, 2025 | Award | +5,740 | – | – | 542,111 |
| Laith L. Yaldoo Director, 10% owner | Jan 1, 2025 | Award | +5,382 | – | – | 536,371 |
| Alison A. Cornell Director | Jan 1, 2025 | Award | +1,516 | – | – | 259,491 |
| Alison A. Cornell Director | Jan 1, 2025 | Award | +8,281 | – | – | 267,772 |
| Mark E. Strome 10% owner | Dec 26, 2024 | Buy | +75,000 | $20.19 | $1.51M | 398,683 |
| Laith L. Yaldoo Director | Oct 16, 2024 | Buy | +3,133 | $15.96 | $50.00K | 533,424 |
| John Bernard Payne President and CEO, Director | Oct 16, 2024 | Buy | +6,343 | $15.76 | $99.97K | 7,909 |
| Mark E. Strome 10% owner | Aug 27, 2024 | Buy | +30,000 | $8.44 | $253.20K | 398,683 |
| Christopher D. Maggiore Director, 10% owner | Aug 22, 2024 | Buy | +31,336 | $8.34 | $261.34K | 498,443 |
| Alison A. Cornell Director | Aug 22, 2024 | Buy | +11,990 | $8.34 | $100.00K | 257,975 |
| Christopher D. Maggiore Director, 10% owner | Jul 26, 2024 | Buy | +2,080 | $8.05 | $16.74K | 467,107 |
| Christopher D. Maggiore Director, 10% owner | Jun 12, 2024 | Buy | +3,764 | $7.97 | $30.00K | 465,027 |
| Nola E. Masterson Director | Jun 11, 2024 | Award | +6,273 | – | – | 122,024 |
| Alison A. Cornell Director | Jun 11, 2024 | Award | +6,273 | – | – | 245,985 |
| Christopher D. Maggiore Director, 10% owner | Jun 11, 2024 | Award | +6,273 | – | – | 461,263 |
| Alison A. Cornell Director | Jun 5, 2024 | Award | +95,134 | $7.96 | $757.27K | 239,712 |
| Alison A. Cornell Director | Jun 5, 2024 | Award | +60,724 | – | – | 144,578 |
| Christopher D. Maggiore Director, 10% owner | Jun 5, 2024 | Award | +81,544 | $7.96 | $649.09K | 454,990 |
| Christopher D. Maggiore Director, 10% owner | Jun 5, 2024 | Award | +36,630 | – | – | 373,446 |
| Nola E. Masterson Director | Jun 5, 2024 | Award | +30,010 | – | – | 30,876 |
| Nola E. Masterson Director | Jun 5, 2024 | Award | +84,941 | $7.96 | $676.13K | 115,817 |
| Alison A. Cornell Director | May 31, 2024 | Award | +37,688 | – | – | 83,854 |
| Alison A. Cornell Director | Jan 2, 2024 | Buy | +41,666 | $1.20 | $50.00K | 68,666 |
| Christopher D. Maggiore Director, 10% owner | Dec 29, 2023 | Buy | +157,692 | $1.30 | $205.00K | 336,816 |
| Christopher D. Maggiore Director, 10% owner | Dec 13, 2023 | Buy | +45,000 | $1.00 | $45.00K | 179,124 |
| Nola E. Masterson Director | Dec 19, 2022 | Buy | +300 | $2.64 | $792 | 5,198 |
| John Bernard Payne President and CEO, Director | Dec 19, 2022 | Buy | +57 | $2.50 | $143 | 9,401 |
| Alison A. Cornell Director | Dec 13, 2022 | Buy | +12,000 | $3.00 | $36.00K | 27,000 |
| Christopher D. Maggiore Director | Sep 14, 2022 | Buy | +5,200 | $3.53 | $18.36K | 721,282 |
| Christopher D. Maggiore Director | Sep 14, 2022 | Buy | +2,000 | $3.55 | $7.10K | 723,282 |
| Christopher D. Maggiore Director, 10% owner | Sep 14, 2022 | Buy | +2,000 | $3.55 | $7.10K | 810,305 |
| Christopher D. Maggiore Director, 10% owner | Sep 14, 2022 | Buy | +5,200 | $3.53 | $18.36K | 808,305 |
| Christopher D. Maggiore Director, 10% owner | Feb 11, 2022 | Buy | +44,965 | $3.87 | $174.01K | 803,105 |
| Christopher D. Maggiore Director, 10% owner | Feb 10, 2022 | Buy | +18,006 | $3.64 | $65.54K | 758,140 |
| Christopher D. Maggiore Director, 10% owner | Feb 9, 2022 | Buy | +28,363 | $3.55 | $100.69K | 740,134 |
| John Bernard Payne Director | Jan 27, 2022 | Buy | +46 | $2.50 | $115 | 9,344 |
| John Bernard Payne Director | Jan 25, 2022 | Buy | +9,122 | $2.50 | $22.81K | 9,298 |
| Christopher D. Maggiore Director, 10% owner | Jan 11, 2022 | Buy | +7,560 | $2.64 | $19.96K | 711,771 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zivo Bioscience's stock actually held short. Settlement fails (shares not delivered on time) peaked at 40 shares on Oct 13, 2026 over the last 90 days.
See a number that looks wrong?